Workflow
盈利预期修正
icon
Search documents
Does XP Inc.A (XP) Have the Potential to Rally 32.21% as Wall Street Analysts Expect?
ZACKS· 2025-11-25 15:56
Core Viewpoint - XP Inc. (XP) shows potential for significant upside, with a mean price target of $23.48 indicating a 32.2% increase from its current price of $17.76 [1] Price Targets and Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $3.41, suggesting variability in analyst predictions [2] - The lowest estimate is $18.30, indicating a 3% increase, while the highest estimate is $30.00, suggesting a potential surge of 68.9% [2] - Analysts' price targets should be approached with caution, as they may not reliably indicate future stock prices [3][7] Earnings Estimates and Analyst Agreement - Analysts are optimistic about XP's earnings, with a consensus indicating better-than-previously estimated earnings [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 0.4% rise in the Zacks Consensus Estimate [12] - XP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Implications of Price Targets - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction [9] - While price targets should not be the sole basis for investment decisions, they can provide a useful starting point for further research [10][14]
Titan Machinery (TITN) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-25 13:56
Core Insights - Titan Machinery (TITN) reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of a loss of $0.36 per share, but down from $0.07 per share a year ago [1] - The earnings surprise was +113.89%, following a previous surprise of +53.57% in the last quarter [2] - The company posted revenues of $644.51 million for the quarter, surpassing the Zacks Consensus Estimate by 10.77%, but down from $679.82 million year-over-year [3] Financial Performance - Titan Machinery has surpassed consensus EPS estimates three times over the last four quarters [2] - The company has topped consensus revenue estimates four times in the last four quarters [3] - The current consensus EPS estimate for the upcoming quarter is -$0.45 on revenues of $613.86 million, and for the current fiscal year, it is -$1.65 on revenues of $2.34 billion [8] Market Position - Titan Machinery shares have increased approximately 16.4% since the beginning of the year, outperforming the S&P 500's gain of 14% [4] - The Zacks Rank for Titan Machinery is currently 3 (Hold), indicating expected performance in line with the market in the near future [7] - The Automotive - Retail and Whole Sales industry, to which Titan Machinery belongs, is currently in the bottom 25% of Zacks industries, which may impact stock performance [9]
Agilent Technologies (A) Matches Q4 Earnings Estimates
ZACKS· 2025-11-24 23:20
分组1 - Agilent Technologies reported quarterly earnings of $1.59 per share, matching the Zacks Consensus Estimate, and showing an increase from $1.46 per share a year ago [1] - The company posted revenues of $1.86 billion for the quarter ended October 2025, exceeding the Zacks Consensus Estimate by 1.49%, compared to $1.7 billion in the same quarter last year [2] - Agilent has surpassed consensus EPS estimates three times and revenue estimates four times over the last four quarters [1][2] 分组2 - The stock has gained approximately 12.6% since the beginning of the year, slightly outperforming the S&P 500's gain of 12.3% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $1.41 for the coming quarter and $5.98 for the current fiscal year [4][7] - The Zacks Industry Rank places the Medical - Products sector in the bottom 36% of over 250 Zacks industries, indicating potential challenges for stock performance [8]
Zoom Communications (ZM) Q3 Earnings and Revenues Surpass Estimates
ZACKS· 2025-11-24 23:20
Core Insights - Zoom Communications reported quarterly earnings of $1.52 per share, exceeding the Zacks Consensus Estimate of $1.43 per share, and showing an increase from $1.38 per share a year ago, resulting in an earnings surprise of +6.29% [1] - The company generated revenues of $1.23 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 1.40% and up from $1.18 billion year-over-year [2] - Zoom has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Performance - The earnings surprise for the previous quarter was +11.68%, with actual earnings of $1.53 per share compared to an expected $1.37 [1] - The current consensus EPS estimate for the upcoming quarter is $1.44, with projected revenues of $1.22 billion, while the estimate for the current fiscal year is $5.83 on $4.83 billion in revenues [7] Stock Performance and Outlook - Zoom shares have declined approximately 3.7% year-to-date, contrasting with the S&P 500's gain of 12.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Internet - Software industry, to which Zoom belongs, is currently ranked in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
UGI (UGI) Reports Q4 Loss, Misses Revenue Estimates
ZACKS· 2025-11-21 00:51
Core Viewpoint - UGI reported a quarterly loss of $0.23 per share, which was better than the Zacks Consensus Estimate of a loss of $0.44, indicating a positive earnings surprise of +47.73% [1] Financial Performance - The company posted revenues of $1.2 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 30.48%, compared to $1.24 billion in revenues a year ago [2] - UGI has surpassed consensus EPS estimates for the last four quarters, but has not beaten revenue estimates during the same period [2] Stock Performance - UGI shares have increased by approximately 23.4% since the beginning of the year, outperforming the S&P 500's gain of 12.9% [3] Future Outlook - The company's earnings outlook will be crucial for determining the sustainability of its stock price movement, with current consensus EPS estimates at $1.32 for the coming quarter and $3.21 for the current fiscal year [4][7] - The estimate revisions trend for UGI was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell), suggesting expected underperformance in the near future [6] Industry Context - The Utility - Gas Distribution industry, to which UGI belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges for stock performance [8]
Copart, Inc. (CPRT) Beats Q1 Earnings Estimates
ZACKS· 2025-11-20 23:26
Core Insights - Copart, Inc. reported quarterly earnings of $0.41 per share, exceeding the Zacks Consensus Estimate of $0.40 per share, and showing an increase from $0.37 per share a year ago, resulting in an earnings surprise of +2.50% [1] - The company generated revenues of $1.16 billion for the quarter ended October 2025, which was 2.55% below the Zacks Consensus Estimate, and a slight increase from $1.15 billion year-over-year [2] - Copart's stock has underperformed, losing approximately 27.9% since the beginning of the year, while the S&P 500 has gained 12.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.42, with expected revenues of $1.21 billion, and for the current fiscal year, the EPS estimate is $1.68 on revenues of $4.87 billion [7] - The estimate revisions trend for Copart was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Auction and Valuation Services industry, to which Copart belongs, is currently ranked in the bottom 16% of over 250 Zacks industries, suggesting potential challenges ahead [8]
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-20 14:11
Core Insights - MediWound reported a quarterly loss of $0.24 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.81, representing an earnings surprise of +70.37% [1] - The company posted revenues of $5.43 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 15.52%, but showing an increase from $4.36 million year-over-year [2] - MediWound has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates two times in the same period [2] Financial Performance - The company experienced a loss of $0.98 per share in the same quarter last year, indicating improvement in financial performance [1] - The current consensus EPS estimate for the upcoming quarter is -$0.85 on revenues of $7.7 million, and for the current fiscal year, it is -$2.69 on revenues of $23.79 million [7] Market Position - MediWound shares have increased by approximately 0.3% since the beginning of the year, underperforming compared to the S&P 500's gain of 12.9% [3] - The Zacks Industry Rank for Medical - Drugs is in the top 29% of over 250 Zacks industries, indicating a favorable industry outlook [8] Future Outlook - The sustainability of MediWound's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The estimate revisions trend for MediWound was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market [6]
All You Need to Know About Virgin Galactic (SPCE) Rating Upgrade to Buy
ZACKS· 2025-11-18 18:01
Virgin Galactic (SPCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a c ...
BellRing Brands (BRBR) Lags Q4 Earnings Estimates
ZACKS· 2025-11-18 14:11
Core Insights - BellRing Brands reported quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.54 per share, representing an earnings surprise of -5.56% [1] - The company posted revenues of $648.2 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.61%, and showing a year-over-year increase from $555.8 million [2] - The stock has underperformed significantly, losing about 66% since the beginning of the year compared to the S&P 500's gain of 13.4% [3] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $0.52 on revenues of $567.87 million, and for the current fiscal year, it is $2.24 on revenues of $2.48 billion [7] - The estimate revisions trend for BellRing Brands was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Food - Miscellaneous industry, to which BellRing Brands belongs, is currently in the bottom 23% of over 250 Zacks industries, suggesting a challenging environment for the stock [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]
Does James River Group (JRVR) Have the Potential to Rally 26.75% as Wall Street Analysts Expect?
ZACKS· 2025-11-17 15:56
Core Viewpoint - James River Group (JRVR) shares have increased by 6.5% recently, with a mean price target of $7.06 indicating a potential upside of 26.8% from the current price of $5.57 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $1.09, where the lowest estimate is $6.00 (7.7% increase) and the highest is $8.00 (43.6% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts are optimistic about JRVR's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which have increased by 10.5% over the past month [11][12] - The Zacks Consensus Estimate indicates that JRVR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as empirical research shows that they often mislead investors [3][7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]